
Join to View Full Profile
250 25th Ave NSte 100Nashville, TN 37203
Phone+1 615-320-5090
Fax+1 615-320-1225
Dr. Thompson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1991 - 1993
Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 1988 - 1991
University of Tennessee Health Science Center College of MedicineClass of 1988
Certifications & Licensure
TN State Medical License 1991 - 2026
NC State Medical License 1989 - 1992
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2012, 2014, 2016-2017
Publications & Presentations
PubMed
- 18 citationsClinical Activity and Safety of Atezolizumab in a Phase 1 Study of Patients With Relapsed/Refractory Small-Cell Lung CancerAnne C. Chiang, Lecia V. Sequist, Jill Gilbert, Paul Conkling, D. S. Thompson
Clinical Lung Cancer. 2020-05-12 - 11 citationsRandomized phase 2 trial of pemetrexed, pemetrexed/bevacizumab, and pemetrexed/carboplatin/bevacizumab in patients with stage IIIB/IV non–small cell lung cancer and an...David R. Spigel, John D. Hainsworth, Mathew John Joseph, Dianna Shipley, M. Kelly Hagan
Cancer. 2018-05-01 - 8 citationsBendamustine, bortezomib and rituximab produces durable complete remissions in patients with previously untreated, low grade lymphoma.Ian W. Flinn, D. S. Thompson, Ralph V. Boccia, Gerald Miletello, Andrew Lipman
British Journal of Haematology. 2018-02-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









